IP Library Assignment 024777/0439
Patent Assignment
Reel/Frame 024777/0439

Confirmatory License

Recorded: 2010-08-02 Pages: 2
Assignor
UNIVERSITY OF CALIFORNIA SAN DIEGO
Executed: 2008-03-02
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property (1)
Treatment of Bladder Diseases with a TLR7 Activator
Application: 12/367,172 →
Publication: US 2009/0202626
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Executive Order 9424, Confirmatory License Mar 10, 2009
From: UNIVERSITY OF CALIFORNIA SAN DIEGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022369/0908 →
Assignment of Assignor's Interest Dec 5, 2009
From: LEONI, LORENZO M.
To: TELORMEDIX SA
Reel/Frame 023619/0100 →
Assignment of Assignor's Interest Dec 5, 2009
From: CARSON, DENNIS A.
To: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE
Reel/Frame 023742/0416 →
Change of Name Nov 13, 2015
From: THERACOAT LTD
To: UROGEN PHARMA LTD
Reel/Frame 037111/0567 →
Asset Purchase Agreement Nov 13, 2015
From: TELORMEDIX SA
To: THERACOAT LTD.
Reel/Frame 037109/0769 →
Change of Name Nov 24, 2015
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 037135/0053 →
Assignment of Assignor's Interest Feb 4, 2016
From: TELORMEDIX, SA
To: UROGEN PHARMA LTD.
Reel/Frame 037668/0353 →